Sign up to save your podcasts
Or
Share The Mix Tape | Special Edition - Cell and Gene Tx Journey to Commercialization: Drug Approval & Post-Approval
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Mix Tape | Special Edition - Cell and Gene Tx Journey to Commercialization: Drug Approval & Post-Approval
In part 2 of our Special Edition Series - Cell and Gene Tx Journey to Commercialization - Abbey Jenkins (CEO, Gamida Cell) and Izzy Tyszler (VP of Commercial, Zevra Therapeutics) join ADVI Health’s Director of Health Policy and Reimbursement, Alicia Silver, to discuss commercialization of gene and cell therapies. Abbey and Izzy share their key learnings from past experiences, advice on how best to prepare for commercialization, and leading commercial teams.
This 2-part special edition, is brought to you by Mix Talent and ADVI Health to bring together women leaders in Cell and Gene Therapy to discuss the journey from manufacturing to commercialization.
View all episodes
By Mix TalentIn part 2 of our Special Edition Series - Cell and Gene Tx Journey to Commercialization - Abbey Jenkins (CEO, Gamida Cell) and Izzy Tyszler (VP of Commercial, Zevra Therapeutics) join ADVI Health’s Director of Health Policy and Reimbursement, Alicia Silver, to discuss commercialization of gene and cell therapies. Abbey and Izzy share their key learnings from past experiences, advice on how best to prepare for commercialization, and leading commercial teams.
This 2-part special edition, is brought to you by Mix Talent and ADVI Health to bring together women leaders in Cell and Gene Therapy to discuss the journey from manufacturing to commercialization.